Precigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86% [Yahoo! Finance]
Precigen, Inc. (NASDAQ: PGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Precigen Reports Third Quarter 2024 Financial Results and Business Updates [Yahoo! Finance]
Precigen Reports Third Quarter 2024 Financial Results and Business Updates
Precigen to Participate in the Stifel 2024 Healthcare Conference